Evolent Health Inc (EVH)
11.39
-0.20
(-1.73%)
USD |
NYSE |
Nov 22, 13:00
Evolent Health Shareholders Equity (Quarterly): 1.039B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 1.039B |
June 30, 2024 | 1.054B |
March 31, 2024 | 1.048B |
December 31, 2023 | 1.068B |
September 30, 2023 | 1.096B |
June 30, 2023 | 1.093B |
March 31, 2023 | 1.292B |
December 31, 2022 | 859.42M |
September 30, 2022 | 856.14M |
June 30, 2022 | 613.09M |
March 31, 2022 | 611.21M |
December 31, 2021 | 693.63M |
September 30, 2021 | 607.48M |
June 30, 2021 | 614.19M |
March 31, 2021 | 617.30M |
December 31, 2020 | 619.60M |
September 30, 2020 | 629.82M |
June 30, 2020 | 646.86M |
March 31, 2020 | 847.07M |
December 31, 2019 | 922.36M |
Date | Value |
---|---|
September 30, 2019 | 1.108B |
June 30, 2019 | 1.131B |
March 31, 2019 | 1.100B |
December 31, 2018 | 1.144B |
September 30, 2018 | 1.039B |
June 30, 2018 | 1.041B |
March 31, 2018 | 1.043B |
December 31, 2017 | 1.011B |
September 30, 2017 | 1.020B |
June 30, 2017 | 859.77M |
March 31, 2017 | 750.47M |
December 31, 2016 | 702.53M |
September 30, 2016 | 562.23M |
June 30, 2016 | 537.73M |
March 31, 2016 | 541.52M |
December 31, 2015 | 649.34M |
September 30, 2015 | 646.67M |
June 30, 2015 | 654.21M |
March 31, 2015 | 7.714M |
December 31, 2014 | -2.07M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
607.48M
Minimum
Sep 2021
1.292B
Maximum
Mar 2023
841.40M
Average
851.60M
Median
Shareholders Equity (Quarterly) Benchmarks
Astrana Health Inc | 704.62M |
American Shared Hospital Services | 26.42M |
Cryo-Cell International Inc | -9.559M |
P3 Health Partners Inc | 120.51M |
Biote Corp | -130.34M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 2.502B |
Total Liabilities (Quarterly) | 1.463B |
Debt to Equity Ratio | 0.5773 |
Current Ratio | 1.039 |
Net Debt Paydown Yield | 0.20% |